￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
The mechanism of acquiring resistance to crizotinib in ALK-rearranged lung cancer

2025-10-19 11:44:20

Check Details
Serious adverse reactions during treatment with crizotinib (Xalkori)

2025-10-19 11:44:20

Check Details
Analysis of the efficacy and adverse reactions of ceritinib in the treatment of advanced ALK-positive lung cancer

2025-10-19 11:44:20

Check Details
The most common adverse reactions of nivolumab in the treatment of non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Analysis of the efficacy and side effects of ramucirumab in the treatment of lung cancer

2025-10-19 11:44:20

Check Details
Side effects and treatment methods of alectinib in the treatment of lung cancer

2025-10-19 11:44:20

Check Details
Analysis of the efficacy and adverse reactions of alectinib in the treatment of ALK-positive lung cancer

2025-10-19 11:44:20

Check Details
Side effects and treatment methods when using lorlatinib to treat non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Side effects and treatment methods of Xalkori in the treatment of ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
How many days will the side effects of Duozerun's treatment of lung cancer last?

2025-10-19 11:44:20

Check Details
What are the side effects of Crizotinib Capsules

2025-10-19 11:44:20

Check Details
How to deal with rash caused by Dacomitinib for lung cancer?

2025-10-19 11:44:20

Check Details
Category
相关知识